超声评价乳腺癌新辅助化疗疗效的准确性研究(2)
 |
| 第1页 |
参见附件。
[2] Bear H D， Anderson S， Smith R E，et al Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphan ide for operable breast cancer National Surgical Adjuvant Breast and bowel Project Protocol B-27[J].J Clin Oncol，2006，24 (13)：2019-2027.
[3] Edge S B，Byrd D R，Compton C C，et al.AJCC Cancer Staging Manual[M].7th Edition.New York：Springer，2010：456-459.
[4] Therasse P， Arbuck S G， Eisenhauer E A，et al. New guidelines to evaluate the response to treatment in solid tumors. European organization for reseach and treatment of cancer， national cancer institute of the united states， National Cancer Institute of Canada [J].J Natl Cancer Inst，2000，92(4)：205-216.
[5] Keune J D，Jeffe D R，Schootman M，et al. Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer [J]. Am J Surg，2010， 199(4)：477-484.
[6] Ogston K N， Miller I D， Payne S， et al. A new histological grading system to assess response of breast cancers to primary chemotherapy： prognostic significance and survival [J].Breast，2003，12(5)：320-327.
[7] Roubidoux M A，Carprntier G L，Fowlkes J B，et al. Sonographic evaluation of early-stage breast cancers that undergo neoadjuvat chemotherapy [J].J Uhrasound Med，2005，24(13)：885-895.
[8] Yeh E， Slanetz P， Kopans D B，et al. Prospective comparing of mammography，sonography，and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer[J].Am J Roentgenol，2005，184(2)：868-877.
(收稿日期：2013-02-19) (编辑：王春芸)
您现在查看是摘要介绍页，详见PDF附件。